Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 35Lung Neoplasms 7Small Cell Lung Carcinoma 2Resectable Non-small Cell Lung Cancer 2Neoplasms 2Squamous-Cell Lung Cancer 1Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Nonsquamous Non-small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1Neoplasm Metastasis 1NSCLC 1Melanoma 1Lymphatic Metastasis 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Bronchogenic 1Carcinoma 1Bronchial Neoplasms 1Advanced Non-small Cell Lung Cancer 1Advanced Non Small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 1Technetium 1Platinum Compounds 1Pemetrexed 1Methylation 1Control Groups 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × Platinum Compounds × Thoracic × Clear all
NCT07538193 2026-04-20

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Tang-Du Hospital

Phase NA Not yet recruiting
28 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡